Verdence Capital Advisors LLC Amgen Inc Transaction History

Verdence Capital Advisors LLC

$1.1 Billion
Q2 2024

A detailed history of Verdence Capital Advisors LLC transactions in Amgen Inc stock. As of the latest transaction made, Verdence Capital Advisors LLC holds 13,952 shares of AMGN stock, worth $4.5 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares

13,952

Previous 12,364 12.84%

Holding current value

$4.5 Million

Previous $3.52 Million 24.01%

% of portfolio

0.39%

Previous 0.32%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	BUY	$262.75 - $319.31 $417,247 - $507,064	1,588 Added 12.84%	13,952 $4.36 Million
Q1 2024 Apr 25, 2024	SELL	$268.87 - $324.56 $150,298 - $181,429	-559 Reduced 4.33%	12,364 $3.52 Million
Q4 2023 Jan 31, 2024	SELL	$255.7 - $288.46 $539,015 - $608,073	-2,108 Reduced 14.02%	12,923 $3.72 Million
Q3 2023 Oct 25, 2023	BUY	$218.65 - $271.46 $720,014 - $893,917	3,293 Added 28.05%	15,031 $4.04 Million
Q2 2023 Jul 28, 2023	BUY	$214.27 - $253.37 $413,541 - $489,004	1,930 Added 19.68%	11,738 $2.61 Million
Q1 2023 Apr 24, 2023	BUY	$225.79 - $275.2 $411,840 - $501,964	1,824 Added 22.85%	9,808 $2.37 Million
Q4 2022 Jan 20, 2023	SELL	$229.03 - $291.01 $469,053 - $595,988	-2,048 Reduced 20.41%	7,984 $0
Q3 2022 Nov 15, 2022	BUY	$224.46 - $253.15 $274,290 - $309,349	1,222 Added 13.87%	10,032 $2.26 Million
Q2 2022 Aug 08, 2022	SELL	$230.71 - $256.74 $249,628 - $277,792	-1,082 Reduced 10.94%	8,810 $2.14 Million
Q1 2022 May 02, 2022	BUY	$219.27 - $242.57 $228,698 - $253,000	1,043 Added 11.79%	9,892 $2.39 Million
Q4 2021 Jan 26, 2022	BUY	$198.88 - $227.6 $244,821 - $280,175	1,231 Added 16.16%	8,849 $1.99 Million
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $566,336 - $663,531	2,668 Added 53.9%	7,618 $1.62 Million
Q2 2021 Aug 06, 2021	BUY	$233.58 - $259.14 $446,838 - $495,734	1,913 Added 62.99%	4,950 $1.21 Million
Q1 2021 May 11, 2021	BUY	$221.91 - $258.6 $70,789 - $82,493	319 Added 11.74%	3,037 $756,000
Q4 2020 Feb 12, 2021	SELL	$216.38 - $257.67 $401,817 - $478,493	-1,857 Reduced 40.59%	2,718 $625,000
Q3 2020 Nov 09, 2020	SELL	$234.65 - $260.95 $573,484 - $637,761	-2,444 Reduced 34.82%	4,575 $1.16 Million
Q2 2020 Aug 11, 2020	SELL	$197.81 - $242.74 $70,024 - $85,929	-354 Reduced 4.8%	7,019 $1.66 Million
Q1 2020 May 13, 2020	BUY	$182.24 - $241.7 $153,446 - $203,511	842 Added 12.89%	7,373 $1.5 Million
Q4 2019 Feb 03, 2020	BUY	$189.21 - $243.2 $271,705 - $349,235	1,436 Added 28.18%	6,531 $1.57 Million
Q3 2019 Mar 06, 2020	SELL	$174.11 - $208.62 $138,591 - $166,061	-796 Reduced 13.51%	5,095 $986,000
Q2 2019 Mar 02, 2020	SELL	$166.7 - $195.41 $58,344 - $68,393	-350 Reduced 5.61%	5,891 $1.09 Million
Q1 2019 Mar 02, 2020	BUY	$180.87 - $203.88 $160,974 - $181,453	890 Added 16.63%	6,241 $1.19 Million
Q4 2018 Feb 25, 2020	BUY	$178.4 - $208.25 $150,034 - $175,138	841 Added 18.65%	5,351 $1.04 Million
Q3 2018 Feb 25, 2020	BUY	$185.29 - $208.89 $490,462 - $552,931	2,647 Added 142.08%	4,510 $935,000
Q2 2018 Feb 11, 2020	BUY	$166.05 - $186.51 $100,294 - $112,652	604 Added 47.97%	1,863 $344,000
Q1 2018 Jan 30, 2020	SELL	$169.43 - $198.0 $32,699 - $38,214	-193 Reduced 13.29%	1,259 $215,000
Q4 2017 Jan 30, 2020	BUY	$168.79 - $188.59 $245,083 - $273,832	1,452	1,452 $252,000

Others Institutions Holding AMGN

# of Institutions

3,054

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $173B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Verdence Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verdence Capital Advisors LLC with notifications on news.

Account

Verdence Capital Advisors LLC Amgen Inc Transaction History